For eligible commercially insured patients, card carries $200 max cap per fill and a maximum benefit of $2,000 per calendar year. You are not eligible if prescriptions are paid by any state or other federally funded programs, including, but not limited to Medicare or Medicaid, Medigap, VA or DOD or TriCare, or where prohibited by law.

If you have any questions, please contact us at 1-844-864-3014 (8:00 AM-8:00 PM EST, Monday-Friday).

VARUBI (rolapitant) 180 mg (two 90-mg tablets) is a prescription medicine called an antiemetic. VARUBI is used with other medicines in adults to help prevent nausea and vomiting that happens later with certain anticancer medicines (chemotherapy).

It is not known if VARUBI is safe and effective in children. Do not use in patients 2 years of age or younger.

Do not take VARUBI if you:

• Are allergic to rolapitant or any of the ingredients in VARUBI. See the end of the Patient Information leaflet in the pocket for a complete list of the ingredients in VARUBI.
• Take thioridazine or pimozide. Taking VARUBI with thioridazine or pimozide can cause serious or life-threatening heart rhythm changes.
• Are 2 years of age or younger.

Before taking VARUBI, tell your doctor if you:

• Have other medical conditions.
• Have liver problems.
• Are pregnant or breastfeeding, or plan to become pregnant or breastfeed.
• Take, or have stopped taking, other prescription or over-the-counter medications. These include vitamins and herbal supplements. Taking VARUBI and other medicines may affect each other and could cause serious side effects.

VARUBI may cause serious side effects, including:

Changes in the level of some medicines in your blood. Serious or life-threatening reactions, including heart rhythm changes, may occur if VARUBI is used with certain other medicines. You should not take VARUBI if you take thioridazine or pimozide.

The most common side effects in patients who take VARUBI with cisplatin chemotherapy include: low white blood cell count, hiccups, and stomach (abdominal) pain.

The most common side effects in patients who take VARUBI with AC (anthracycline and cyclophosphamide) or certain other types of chemotherapy include: decreased appetite, low white blood cell count, dizziness, indigestion, urinary tract infection, mouth sores, and low red blood cell count.

These are not all of the possible side effects of VARUBI. Call your doctor for medical advice about side effects.

Please see the Prescribing Information for more information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

You may also contact TerSera Therapeutics at 1-844-334-4035 or medicalinformation@tersera.com.

This site is intended for US consumers only.

The information on this Web site should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about VARUBI, talk to your doctor or pharmacist. Only you and your health care professional can decide if VARUBI is right for you.